Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer

Lung cancer is the leading cause of cancer-related death worldwide. Metabolic reprogramming is a fundamental trait associated with lung cancer development that fuels tumor proliferation and survival. Monitoring such metabolic pathways and their intermediate metabolites can provide new avenues concer...

Full description

Bibliographic Details
Main Author: Atiah H. Almalki
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/10/1037
_version_ 1797572982594338816
author Atiah H. Almalki
author_facet Atiah H. Almalki
author_sort Atiah H. Almalki
collection DOAJ
description Lung cancer is the leading cause of cancer-related death worldwide. Metabolic reprogramming is a fundamental trait associated with lung cancer development that fuels tumor proliferation and survival. Monitoring such metabolic pathways and their intermediate metabolites can provide new avenues concerning treatment strategies, and the identification of prognostic biomarkers that could be utilized to monitor drug responses in clinical practice. In this review, recent trends in the analytical techniques used for metabolome mapping of lung cancer are capitalized. These techniques include nuclear magnetic resonance (NMR), gas chromatography–mass spectrometry (GC-MS), liquid chromatography–mass spectrometry (LC-MS), and imaging mass spectrometry (MSI). The advantages and limitations of the application of each technique for monitoring the metabolite class or type are also highlighted. Moreover, their potential applications in the analysis of many biological samples will be evaluated.
first_indexed 2024-03-10T21:03:16Z
format Article
id doaj.art-22e65987c1db43218f1249fdcb90b268
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-10T21:03:16Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-22e65987c1db43218f1249fdcb90b2682023-11-19T17:19:33ZengMDPI AGMetabolites2218-19892023-09-011310103710.3390/metabo13101037Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung CancerAtiah H. Almalki0Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi ArabiaLung cancer is the leading cause of cancer-related death worldwide. Metabolic reprogramming is a fundamental trait associated with lung cancer development that fuels tumor proliferation and survival. Monitoring such metabolic pathways and their intermediate metabolites can provide new avenues concerning treatment strategies, and the identification of prognostic biomarkers that could be utilized to monitor drug responses in clinical practice. In this review, recent trends in the analytical techniques used for metabolome mapping of lung cancer are capitalized. These techniques include nuclear magnetic resonance (NMR), gas chromatography–mass spectrometry (GC-MS), liquid chromatography–mass spectrometry (LC-MS), and imaging mass spectrometry (MSI). The advantages and limitations of the application of each technique for monitoring the metabolite class or type are also highlighted. Moreover, their potential applications in the analysis of many biological samples will be evaluated.https://www.mdpi.com/2218-1989/13/10/1037metabolomicslung cancerNMRGC-MSLC-MSMSI
spellingShingle Atiah H. Almalki
Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
Metabolites
metabolomics
lung cancer
NMR
GC-MS
LC-MS
MSI
title Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
title_full Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
title_fullStr Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
title_full_unstemmed Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
title_short Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
title_sort recent analytical advances for decoding metabolic reprogramming in lung cancer
topic metabolomics
lung cancer
NMR
GC-MS
LC-MS
MSI
url https://www.mdpi.com/2218-1989/13/10/1037
work_keys_str_mv AT atiahhalmalki recentanalyticaladvancesfordecodingmetabolicreprogramminginlungcancer